Lung Cancer Canada Names New President

June 15, 2021

From the Office of the Executive Director:
 
Lung Cancer Canada held its annual general meeting virtually on June 14, with board members from across Canada electing a new President and one new board member to Lung Cancer Canada’s Board of Directors.

I am pleased to announce Dr. Stephanie Snow has been elected President of Lung Cancer Canada. Since our inception in 2002, LCC has been guided by leaders who possess a unique balance of purposeful strength, vision, and compassion. Dr. Snow embodies a commitment to service that resonates with our mandate to provide supports for lung cancer patients and their families.

Message from Dr. Stephanie Snow, President of Lung Cancer Canada
I am honoured to be assuming the role of President of Lung Cancer Canada, as the values that inform its mandate are the same that I bring to my own work as a Medical Oncologist - caring for, supporting, and advocating for lung cancer patients.  I am fortunate to come into this role at a time when Lung Cancer Canada has been well established with a track record of effective programs in patient education and support, research and also providing a strong voice of support for access to therapies and screening.  There still remains a lot to be accomplished, as there is great disparity across Canada, in that all lung cancer patients do not receive the same care and access to supports.  Moving forward, I would like to focus on equity in lung cancer by working on those regional and social determinants of health that make lung cancer a postal code disease in Canada.  I thank Dr. Wheatley-Price for his past service as president and hope my term will be as productive as his was with the support of the whole team at Lung Cancer Canada.

Message from Dr. Paul Wheatley-Price, Immediate Past President of Lung Cancer Canada
Over the past 5 years it has been my distinct privilege to serve as President of Lung Cancer Canada, and it has been a time where we have seen the charity grow and be able to support more lung cancer patients and their families than ever before, in all provinces and territories across the country. It has been an exciting time in lung cancer, with new treatments and lung cancer screening in particular promising better results for patients. LCC has been proud to advocate for these advances and access to them, to fight stigma, and to keep patients supported and informed with educational events, materials, support groups, webinars, podcast and much, much more. We are truly a national organization, and as I pass on the Presidency to Dr. Snow, the future looks brighter and brighter.
 
Dr. Snow has been a staff Medical Oncologist at the QEII hospital in Halifax, Nova Scotia since 2010 and is currently an Associate Professor at the Faculty of Medicine at Dalhousie. After pursuing undergraduate training at McGill, she completed her MD, Internal Medicine and Medical Oncology training at Dalhousie. She treats head and neck, thoracic and GI malignancies. Academically, she has a strong interest in Medical Education, overseeing the Dalhousie Undergraduate Medical Oncology program and contributing to national oncology education initiatives. She participates in clinical research in areas relevant to her treatment sites and has been published in many journals including the Journal of Thoracic Oncology, the Canadian Medical Association Journal (CMAJ), the Oncologist, and Current Oncology.

I would like to thank Immediate Past President Dr. Paul Wheatley-Price for his outstanding contributions not only to LCC and the lung cancer community in Canada but throughout the world. Paul exemplifies true leadership during challenging times, his strength has been our strength and his vision truly is supporting.

I would also like to recognize our retiring board members. Sumbul Ali has served as Lung Cancer Canada’s Corporate Secretary for years. Her advice and hard work have been an immense asset to LCC. Roz Brodsky has been a member of the LCC board for many years.  She was one of the members of the board who is also a lung cancer survivor.  She was tireless in making sure that the patient voice was heard. I thank Roz and Sumbul for their commitment, dedication, and hard work on behalf of Lung Cancer Canada.

I am pleased to announce Emi Bossio has been elected Corporate Secretary of Lung Cancer Canada. Emi is a litigation lawyer with over 20 years of experience.  Emi has been recognized by Benchmark Litigation as one of the Top 25 Female Litigators in Canada and as a Litigation Star.  She has been listed by Best Lawyers in Canada in the areas of Corporate Commercial Litigation, Alternative Dispute Resolution, Appellate Advocacy and Labour and Employment.  In 2019, at age 47, Emi became one of the increasing number of never smokers diagnosed with lung cancer.   She hopes to raise awareness and advocate for research, support and equitable funding for lung cancer patients and their caregivers. Emi lives in Calgary with her husband and 2 children.

I welcome both new and returning Board members to our National Board. We are grateful to have such talented and respected leaders on our team whose shared vision, expertise and abilities will ensure that LCC continues to be the leading resource for the lung cancer community in Canada.  
 
Lung Cancer Canada is a registered national charity (#872775119  RR0001) that serves as Canada’s leading resource for lung cancer education, patient support, research and advocacy. Based in Toronto, Ontario, Lung Cancer Canada has a wide reach that includes both regional and pan-Canadian initiatives. Lung Cancer Canada is a member of the Global Lung Cancer Coalition and is the only national charitable organization in Canada focused exclusively on lung cancer.

For more information contact:
Shem Singh
Email: [email protected]canada.ca
Phone: 416-785-3439